Osteocalcin: Skeletal and extra-skeletal effects

Journal of Cellular Physiology

Volumn 228, Issue 6, 2013, Pages 1149-1153

  Neve, Anna ^a   Corrado, Addolorata ^a   Cantatore, Francesco Paolo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; COLECALCIFEROL; LEPTIN; OSTEOCALCIN; RISEDRONIC ACID; TRANSCRIPTION FACTOR RUNX2; VITAMIN K GROUP;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ARTICLE; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CATABOLISM; CELL PROLIFERATION; ENERGY METABOLISM; GENETIC TRANSCRIPTION; INSULIN RELEASE; INSULIN RESISTANCE; MALE FERTILITY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PANCREAS ISLET BETA CELL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADIPOSITY; ANIMALS; BONE AND BONES; BONE REMODELING; CALCINOSIS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOCALCIN; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 84874201574     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24278     Document Type: Article

References (97)

1. Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. 2009. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med 218:201-205.
2. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. 2002. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 76:1055-1060.
3. Bodine PV, Komm BS. 1999. Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor. Bone 25:535-543.
4. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, Cupples LA, Wilson PW, Kiel DP. 2004. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 89:4904-4909.
5. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. 2008. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93:1217-1223.
6. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. 1998. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187-196.
7. Boskey AL, Wians FH, Jr., Hauschka PV. 1985. The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth. Calcif Tissue Int 37:57-62.
8. Boucher-Berry C, Speiser PW, Carey DE, Shelov SP, Accacha S, Fennoy I, Rapaport R, Espinal Y, Rosenbaum M. 2012. Vitamin D, osteocalcin and risk for adiposity as co-morbidities in middle school children. J Bone Miner Res 27:283-293.
9. Boudreaux JM, Towler DA. 1996. Synergistic induction of osteocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J Biol Chem 271:7508-7515.
10. Cantatore FP, Corrado A, Grano M, Quarta L, Colucci S, Melillo N. 2004. Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clin Rheumatol 23:490-495.
11. Cantatore FP, Crivellato E, Nico B, Ribatti D. 2005. Osteocalcin is angiogenic in vivo. Cell Biol Int 29:583-585.
12. Carvallo L, Henríquez B, Paredes R, Olate J, Onate S, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M. 2008. 1alpha, 25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha, 25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex. J Cell Physiol 214:740-749.
13. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ. 1994. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 127:1149-1158.
14. DeFranco DJ, Glowacki J, Cox KA, Lian JB. 1991. Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo. Calcif Tissue Int 49:43-50.
15. Delmas PD, Christiansen C, Mann KG, Price PA. 1990. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 5:5-11.
16. Doi Y, Horiguchi T, Kim SH, Moriwaki Y, Wakamatsu N, Adachi M, Shigeta H, Sasaki S, Shimokawa H. 1993. Immobilized DPP and other proteins modify OCP formation. Calcif Tissue Int 52:139-145.
17. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452.
18. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207.
19. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520.
20. Emaus N, Nguyen ND, Almaas B, Berntsen GK, Center JR, Christensen M, Gjesdal CG, Grimsgaard AS, Nguyen TV, Salomonsen L, Eisman JA, Fønnebø VM. 2011. Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women. Eur J Nutr [Epub ahead of print].
21. Ferron M, Hinoi E, Karsenty G, Ducy P. 2008. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270.
22. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. 1999. Vitamin K intake and hip fractures in women: A prospective study. Am J Clin Nutr 69:74-79.
23. Fleet JC, Hock JM. 1994. Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction. J Bone Miner Res 9:1565-1573.
24. Garnero P, Grimaux M, Seguin P, Delmas PD. 1994. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 9:255-264.
25. Gorski JP. 2011. Biomineralization of bone: A fresh view of the roles of non-collagenous proteins. Front Biosci 17:2598-2621.
26. Gössl M, Mödder UI, Atkinson EJ, Lerman A, Khosla S. 2008. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 52:1314-1325.
27. Gundberg CM, Nieman SD, Abrams S, Rosen H. 1998. Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266.
28. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T. 2003. Effect of weight loss on bone metabolism: Comparison of vertical banded gastroplasty and medical intervention. Obes Surg 13:383-388.
29. Gutierrez S, Liu J, Javed A, Montecino M, Stein GS, Lian JB, Stein JL. 2004. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J Biol Chem 279:43581-43588.
30. Harada I. 1992. The effects of glucocorticoids on angiogenesis in vitro. Nihon Seikeigeka Gakkai Zasshi 66:763-770.
31. Hauschka PV, Lian JB, Cole DE, Gundberg CM. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047.
32. Hoang QQ, Sicheri F, Howard AJ, Yang DS. 2003. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425:977-980.
33. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD. 1993. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8:1241-1245.
34. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. 1999. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389.
35. Hozuki T, Imai T, Tsuda E, Matsumura A, Yamamoto D, Toyoshima T, Suzuki S, Yamauchi R, Hayashi T, Hisahara S, Shimohama S. 2010. Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: A pilot study. Intern Med 49:371-376.
36. Hughes-Fulford M, Li CF. 2011. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J Orthop Surg Res 6:8.
37. Hunter GK, Hauschka PV, Poole AR, Rosenerg LC, Goldberg HA. 1996. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317:59-64.
38. Hwang YC, Jeong IK, Ahn KJ, Chung HY. 2009. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25:768-772.
39. Ingram RT, Park YK, Clarke BL, Fitzpatrick LA. 1994. Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling. J Clin Invest 93:989-997.
40. Inoue T, Fujita T, Kishimoto H, Makino T, Nakamura T, Nakamura T, Sato T, Yamazaki K. 2009. Randomized controlled study on the prevention of osteoporotic fractures (OF study): A phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab 27:66-75.
41. Ishida M, Amano S. 2004. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J Bone Miner Metab 22:415-429.
42. Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. 2004. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361-18369.
43. Javed A, Gutierrez S, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 1999. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol 19:7491-7500.
44. Jung C, Ou YC, Yeung F, Frierson HF, Jr., Kao C. 2001. Osteocalcin is incompletely spliced in non-osseous tissues. Gene 271:143-150.
45. Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H. 2001. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk. Nutrition 17:315-321.
46. Knepper-Nicolai B, Reinstorf A, Hofinger I, Flade K, Wenz R, Pompe W. 2002. Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D. Biomol Eng 19:227-231.
47. Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB. 2009. Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mech Behav Biomed Mater 2:348-354.
48. 3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int 59:466-473.
49. Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Ann Clin Biochem 2000. 37:432-446.
50. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469.
51. Lee SW, Jo HH, Kim MR, You YO, Kim JH. 2011. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol [Epub ahead of print].
52. Lian JB, Tassinari M, Glowacki J. 1984. Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest 73:1223-1226.
53. Liggett WH, Jr., Lian JB, Greenberger JS, Glowacki J. 1994. Osteocalcin promotes differentiation of osteoclast progenitors from murine long-term bone marrow cultures. J Cell Biochem 55:190-199.
54. Liu G, Peacock M. 1998. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286-289.
55. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ. 1982. Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227-230.
56. Martínez ME, del Campo MT, Medina S, Sánchez M, Sánchez-Cabezudo MJ, Esbrit P, Martínez P, Moreno I, Rodrigo A, Garcés MV, Munuera L. 1999. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation. Calcif Tissue Int 64:280-286.
57. Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE. 1994. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem 269:30659-30667.
58. McDonnell DP, Scott RA, Kerner SA, O'Malley BW, Pike JW. 1989. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol Endocrinol 3:635-644.
59. Menanteau J, Neuman WF, Neuman MW. 1982. A study of bone proteins which can prevent hydroxyapatite formation. Metab Bone Dis Relat Res 4:157-162.
60. Mosavin R, Mellon WS. 1996. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1, 25-dihydroxyvitamin D3. Arch Biochem Biophys 332:142-152.
61. Mundy GR, Poser JW. 1983. Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 35:164-168.
62. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS. 2004. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841.
63. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309.
64. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G. 2011. Endocrine regulation of male fertility by the skeleton. Cell 144:796-809.
65. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. 1991. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496-1504.
66. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW. 1990. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888.
67. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M. 2004. Bone-specific transcription factor Runx2 interacts with the 1alpha, 25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24:8847-8861.
68. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD. 1991. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 6:1211-1216.
69. Plaza SM, Lamson DW. 2005. Vitamin K2 in bone metabolism and osteoporosis. Altern Med Rev 10:24-35.
70. Price PA, Nishimoto SK. 1980. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77:2234-2238.
71. Price PA, Urist MR, Otawara Y. 1983. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117:765-771.
72. Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C. 1989. Chromosomal localization of the human osteocalcin gene. Endocrinology 124:2648-2650.
73. Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK, Härkönen P. 1998. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22:201-209.
74. Rammelt S, Neumann M, Hanisch U, Reinstorf A, Pompe W, Zwipp H, Biewener A. 2005. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res A 73:284-294.
75. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. 2001. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264:317-324.
76. Ricci TA, Heymsfield SB, Pierson RN, Jr., Stahl T, Chowdhury HA, Shapses SA. 2001. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 73:347-352.
77. Romberg RW, Werness PG, Riggs BL, Mann KG. 1986. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 25:1176-1180.
78. Salo J, Lehenkari P, Mulari M, Metsikkö K, Väänänen HK. 1997. Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
79. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM. 2011. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: Parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 96:E1982-E1989.
80. Shalhoub V, Aslam F, Breen E, van Wijnen A, Bortell R, Stein GS, Stein JL, Lian JB. 1998. Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: Glucocorticoid regulation of basal and vitamin D stimulated gene expression. J Cell Biochem 69:154-168.
81. Shea MK, O'Donnell CJ, Vermeer C, Magdeleyns EJ, Crosier MD, Gundberg CM, Ordovas JM, Kritchevsky SB, Booth SL. 2011. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 141:1529-1534.
82. Shearer MJ, Fu X, Booth SL. 2012. Vitamin K nutrition, metabolism, and requirements: Current concepts and future research. Adv Nutr 3:182-195.
83. Shen J, Montecino M, Lian JB, Stein GS, Van Wijnen AJ, Stein JL. 2002. Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D-dependent, bone tissue-specific transcription. J Biol Chem 277:20284-20292.
84. Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL, Van Wijnen AJ. 2003. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol 17:743-756.
85. Spronk HM, Soute BA, Schurgers LJ, Cleutjens JP, Thijssen HH, De Mey JG, Vermeer C. 2001. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 289:485-490.
86. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. 1994. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591-1595.
87. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. 1996. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 18:487-488.
88. 2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27:769-776.
89. Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimoto SK. 1994. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135:929-937.
90. Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. 1998. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1, 25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem 273:8483-8491.
91. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Lumpkin CK, Jr., Fowlkes JL. 2011. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int [Epub ahead of print].
92. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, Okano T. 2008. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Min Metab 26:79-85.
93. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. 1997. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study. J Clin Endocrinol Metab 82:719-724.
94. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O'Brien CA, Thostenson J, Roberson PK, Boskey AL, Clemens TL, Manolagas SC. 2010. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9:147-161.
95. Wolf G. 1996. Function of the bone protein osteocalcin: Definitive evidence. Nutr Rev 54:332-333.
96. Young MF. 2003. Bone matrix proteins: Their function, regulation, and relationship to osteoporosis. Osteoporos Int 14:S35-S42.
97. Yu XP, Chandrasekhar S. 1997. Parathyroid hormone (PTH 1-34) regulation of rat osteocalcin gene transcription. Endocrinology 138:3085-3092.